These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8599863)

  • 1. High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model.
    Smeland E; Fuskevåg OM; Nymann K; Svendesn JS; Olsen R; Lindal S; Bremnes RM; Aarbakke J
    Cancer Chemother Pharmacol; 1996; 37(5):415-22. PubMed ID: 8599863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat.
    Smeland E; Bremnes RM; Andersen A; Jaeger R; Eide TJ; Huseby NE; Aarbakke J
    Cancer Chemother Pharmacol; 1994; 34(2):119-24. PubMed ID: 8194163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maximum tolerated doses of methotrexate and 7-hydroxy-methotrexate in a model of acute toxicity in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Cancer Chemother Pharmacol; 2000; 46(1):69-73. PubMed ID: 10912581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephalosporins increase the renal clearance of methotrexate and 7-hydroxymethotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1990; 26(2):139-43. PubMed ID: 2189590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 7-Hydroxymethotrexate concentrations in serum and cerebrospinal fluid of children with acute lymphoblastic leukemia.
    Borsi JD; Sagen E; Romslo I; Slørdal L; Moe PJ
    Cancer Chemother Pharmacol; 1990; 27(2):164-7. PubMed ID: 2249335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
    Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
    Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucovorin and maximum tolerated dose toxicity of methotrexate in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Pediatr Hematol Oncol; 2000 Dec; 17(8):651-8. PubMed ID: 11127396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent pharmacokinetics of methotrexate and 7-hydroxymethotrexate in the rat in vivo.
    Bremnes RM; Slørdal L; Wist E; Aarbakke J
    Cancer Res; 1989 Nov; 49(22):6359-64. PubMed ID: 2804982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in methotrexate pharmacokinetics by naproxen in the rat as measured by microdialysis.
    Ekstrøm PO; Giercksky KE; Andersen A; Slørdal L
    Life Sci; 1997; 60(24):PL 359-64. PubMed ID: 9188769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hepatotoxicity after high-dose methotrexate administration to rats.
    Bremnes RM; Smeland E; Huseby NE; Eide TJ; Aarbakke J
    Pharmacol Toxicol; 1991 Aug; 69(2):132-9. PubMed ID: 1775433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of plasma methotrexate and 7-hydroxy methotrexate by UHPLC-MS/MS in patients receiving high-dose methotrexate therapy.
    Mei S; Shi X; Du Y; Cui Y; Zeng C; Ren X; Yu K; Zhao Z; Lin S
    J Pharm Biomed Anal; 2018 Sep; 158():300-306. PubMed ID: 29909319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-Hydroxy-methotrexate and clinical toxicity following high-dose methotrexate therapy.
    Erttmann R; Bielack S; Landbeck G
    J Cancer Res Clin Oncol; 1985; 109(1):86-8. PubMed ID: 3855853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration.
    Bremnes RM; Slørdal L; Wist E; Aarbakke J
    Cancer Res; 1989 May; 49(9):2460-4. PubMed ID: 2706634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of 7-hydroxymethotrexate formation by amsacrine.
    Bremnes RM; Smeland E; Willassen NP; Wist E; Aarbakke J
    Cancer Chemother Pharmacol; 1991; 28(5):377-83. PubMed ID: 1914082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of 7-hydroxymethotrexate during methotrexate anti-cancer therapy.
    Lankelma J; van der Klein E; Ramaekers F
    Cancer Lett; 1980 Apr; 9(2):133-42. PubMed ID: 7189691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural changes in rat livers perfused in vitro and in vivo with a high dose of methotrexate.
    Al-Ali SY; Hassan IM; Sadek S
    Histol Histopathol; 2005 Oct; 20(4):1131-45. PubMed ID: 16136496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 7-hydroxy-methotrexate and methotrexate in the rat.
    Slørdal L; Jaeger R; Kjaeve J; Aarbakke J
    Pharmacol Toxicol; 1988 Aug; 63(2):81-4. PubMed ID: 3186623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of 7-hydroxymethotrexate polyglutamyl derivatives and their cytotoxicity in human chronic myelogenous leukemia cells, in vitro.
    Fabre G; Goldman ID
    Cancer Res; 1985 Jan; 45(1):80-5. PubMed ID: 2578101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose leucovorin as sole therapy for methotrexate toxicity.
    Flombaum CD; Meyers PA
    J Clin Oncol; 1999 May; 17(5):1589-94. PubMed ID: 10334548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1988; 21(4):337-42. PubMed ID: 3370743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.